<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05612412</url>
  </required_header>
  <id_info>
    <org_study_id>GFHNRC154</org_study_id>
    <nct_id>NCT05612412</nct_id>
  </id_info>
  <brief_title>Exercise for Better Bones - Day or Night?</brief_title>
  <official_title>Bone Metabolic Responses to Morning Versus Evening Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>USDA Grand Forks Human Nutrition Research Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>USDA Grand Forks Human Nutrition Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out if moderate exercise at different time during the&#xD;
      day (early morning vs early evening) affects biomarker CTX of bone health in normal to&#xD;
      overweight postmenopausal women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall objective of this study is to investigate whether the daily timing of exercise&#xD;
      affects bone turnover markers in postmenopausal women. Results from this clinical trial will&#xD;
      provide valuable information to support guidelines of physical activity for people to improve&#xD;
      musculoskeletal health, especially post-menopausal women. The scientific questions that will&#xD;
      be investigated are:&#xD;
&#xD;
        1. What are the acute effects of the daily timing of exercise on serum concentrations of&#xD;
           bone turnover markers and 24-h total urinary calcium excretion?&#xD;
&#xD;
        2. Are differences in initial exercise-induced responses of bone turnover markers and&#xD;
           urinary Ca excretion maintained across two weeks of exercise training?&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 2023</start_date>
  <completion_date type="Anticipated">May 2025</completion_date>
  <primary_completion_date type="Anticipated">May 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in serum C-terminal telopeptide of type 1 collagen (CTX)</measure>
    <time_frame>Day 1, Day 15</time_frame>
    <description>Test the differences in morning peak serum CTX following one bout of exercise per day for 10 days over a two-week period in either the early morning or the evening.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Morning Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Morning exercise session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Evening Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evening exercise session</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Morning Exercise</intervention_name>
    <description>Standardized treadmill exercise session starting at approximately 0700</description>
    <arm_group_label>Morning Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evening Exercise</intervention_name>
    <description>Standardized treadmill exercise session starting at approximately 1800</description>
    <arm_group_label>Evening Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Postmenopausal women within 1-10 yr after menopause&#xD;
&#xD;
          -  BMI 18.5-29.9 kg/m2&#xD;
&#xD;
          -  Healthy as determined by a screening physical examination and blood chemistry related&#xD;
             to thyroid, liver, kidney, and lipid profile within normal range&#xD;
&#xD;
          -  No osteoporosis as determined by dual energy x-ray absorptiometry (DEXA) scan at&#xD;
             femoral neck or total spinal region&#xD;
&#xD;
          -  No regular exercise for more than 30 minutes a day on more than 2 days a week and no&#xD;
             physically active employment, such as maintenance and repair or delivery worker&#xD;
&#xD;
          -  No regular use of medications known to interfere with calcium and bone metabolism from&#xD;
             6 weeks prior to the study to the end of study such as medications for heartburn,&#xD;
             reflux, H2 blockers, diuretics, etc. such as antacids, Maalox, Pepcid AC, Nexium,&#xD;
             Diuril, etc.&#xD;
&#xD;
          -  Weight stable (within 5 lbs change) for at least 3 months prior to the start of the&#xD;
             study&#xD;
&#xD;
          -  Willing to maintain usual lifestyle and activities including the same wake-sleep&#xD;
             schedule (go to sleep between 10:00 p.m. and midnight with an average 6-8 hours of&#xD;
             sleep time)&#xD;
&#xD;
          -  Refrain from the use of alcohol and nicotine (for example, cigarettes, cigars, and&#xD;
             e-cigarettes) for the length of the study&#xD;
&#xD;
          -  Able and willing to perform moderate intensity exercise without contraindications as&#xD;
             determined by the Physical Activity Readiness Questionnaire&#xD;
&#xD;
          -  Willing and able to stop any nutritional supplements including vitamin D supplements&#xD;
             and calcium-containing medications (for instance, calcium-carbonate antacids)&#xD;
&#xD;
          -  Willing not to use tanning booths during the study or not to travel to locations with&#xD;
             a tropical climate two weeks prior to the study or during the washout period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hypertension with resting blood pressure higher than systolic 140 and diastolic 90&#xD;
             mmHg&#xD;
&#xD;
          -  Within past 6 weeks, had nutrition supplements or medications known to affect calcium&#xD;
             metabolism and appetite such as Antacids, Megace, antacids, heartburn, reflux, H2&#xD;
             blockers, diuretics, etc.&#xD;
&#xD;
          -  Allergy to any food ingredients used in the provided diet&#xD;
&#xD;
          -  Any disorders affecting nutrient absorption or metabolism, such as cystic fibrosis,&#xD;
             lactose intolerance, celiac disease, etc.&#xD;
&#xD;
          -  Any sleep disorders such as sleep apnea or regular use of an over-the-counter&#xD;
             melatonin supplement&#xD;
&#xD;
          -  Diabetes or taking medications known to affect bone such as Actos, Avandia, Invokana,&#xD;
             etc.&#xD;
&#xD;
          -  Engaged in moderate to vigorous exercise or regular exercise for more than 30&#xD;
             minutes/day on more than 2 days/week within past 6 weeks&#xD;
&#xD;
          -  Repeated non-compliance with completing prescribed exercise sessions&#xD;
&#xD;
          -  Within past 6 weeks, used tanning booths or traveled to location with a tropic climate&#xD;
&#xD;
          -  Use of antibiotics (Amoxicillin, doxycycline, etc.), nonsteroidal anti-inflammatory&#xD;
             drugs (aspirin, Celebrex, etc.), or probiotics (Lactobacillus, Bifidobacterium) within&#xD;
             the past 6 weeks&#xD;
&#xD;
          -  Irritable bowel syndrome, inflammatory bowel disease, or not having a bowel movement&#xD;
             three days or longer&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jay Cao, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>USDA Grand Forks Human Nutrition Research Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jay Cao, PhD</last_name>
    <phone>701-795-8377</phone>
    <email>jay.cao@usda.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>USDA Grand Forks Human Nutrition Research Center</name>
      <address>
        <city>Grand Forks</city>
        <state>North Dakota</state>
        <zip>58203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela J Scheett, MPH, RD</last_name>
      <phone>701-795-8386</phone>
      <email>angela.scheett@usda.gov</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.ars.usda.gov/plains-area/gfnd/gfhnrc/docs/nutrition-studies/nutrition-studies/</url>
    <description>Grand Forks Human Nutrition Research Center Current Nutrition Studies</description>
  </link>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>November 3, 2022</study_first_submitted>
  <study_first_submitted_qc>November 3, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2022</study_first_posted>
  <last_update_submitted>March 19, 2023</last_update_submitted>
  <last_update_submitted_qc>March 19, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>USDA Grand Forks Human Nutrition Research Center</investigator_affiliation>
    <investigator_full_name>Jay Cao</investigator_full_name>
    <investigator_title>Research Nutritionist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

